A patient implanted with Neuralink’s brain chip has achieved full recovery, showcasing the ability to control a computer mouse using mere thoughts.
Neuralink’s device comprises a sophisticated chip and electrode array featuring over 1,000 flexible conductors delicately threaded into the cerebral cortex.
These electrodes adeptly capture thoughts associated with motion, empowering users to seamlessly manipulate devices such as phones or computers through pure mental commands.
Originally designed for individuals with limb loss, the ultimate aim of Neuralink is to revolutionize communication speed, envisioning capabilities that surpass even accomplished typists like Stephen Hawking.
While the initial mission involved merging human brains with AI, Neuralink has pivoted towards perfecting brain-computer interfaces.
The FDA granted approval for Neuralink’s chip to enter human clinical trials in May 2023, with enrollment for a study involving quadriplegic participants commencing in September of the same year.
However, the ambitious project has not been without controversy.
Neuralink has faced criticism and ethical concerns, particularly concerning the well-being of monkeys used in trials.
Reports have surfaced detailing suffering among the animals, leading to euthanasia due to complications such as bloody diarrhea, partial paralysis, and brain swelling.
These challenges underscore the ethical considerations and potential risks associated with pushing the boundaries of neurotechnology.
